Skip to main content

Advertisement

SpringerLink
Log in

Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

Lung transplantation (LTX) is nowadays accepted as a treatment option for selected patients with end-stage pulmonary disease. Idiopathic pulmonary fibrosis (IPF) is characterized by the radiological and histologic appearance of usual interstitial pneumonia. It is associated with a poor prognosis, and LTX is considered an effective treatment to significantly modify the natural history of this disease. The aim of the present study was to analyse mortality during the waiting list in IPF patients at a single institution.

Methods

A retrospective analysis on IPF patients (n = 90) referred to our Lung Transplant Program in the period 2001–2014 was performed focusing on patients’ characteristics and associated risk factors.

Results

Diagnosis of IPF was associated with high mortality on the waiting list with respect to other diagnosis (p < 0.05). No differences in demographic, clinical, radiological data and time spent on the waiting list were observed between IPF patients who underwent to LTX or lost on the waiting list. Patients who died showed significant higher levels of pCO2 and needed higher flows of O2-therapy on effort (p < 0.05). Pulmonary function tests failed to predict mortality and no other medical conditions were associated with survival.

Conclusions

Patients newly diagnosed with IPF, especially in small to medium lung transplant volume centres and in Countries where a long waiting list is expected, should be immediately referred to transplantation, delay results in increased mortality. Early identification of IPF patients with a rapid progressive phenotype is strongly needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

IPF:

Idiopathic pulmonary fibrosis

UIP:

Usual interstitial pneumonia

LTX:

Lung transplantation

References

  1. Orens JB, Estenne M, Arcasoy S, Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation et al (2006) International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25(7):745–755

    Article  PubMed  Google Scholar 

  2. Trulock EP, Christie JD, Edwards LB et al (2007) Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report—2007. J Heart Lung Transplant 26(8):782–795

    Article  PubMed  Google Scholar 

  3. Meyer KC, Raghu G, Verleden GM, ISHLT/ATS/ERS BOS Task Force Committee et al (2014) An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J 44(6):1479–1503

    Article  PubMed  Google Scholar 

  4. Raghu G, Collard HR, Egan JJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824

    Article  PubMed  Google Scholar 

  5. Cottin V, Le Pavec J, Prévot G et al (2010) Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 35(1):105–111

    Article  CAS  PubMed  Google Scholar 

  6. Castria D, Refini RM, Bargagli E et al (2012) Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress. Int J Immunopathol Pharmacol. 25(3):681–689

    CAS  PubMed  Google Scholar 

  7. Spagnolo P, Del Giovane C, Luppi F et al (2010) Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev (9):CD003134. doi:10.1002/14651858.CD003134.pub2

  8. King TE Jr, Bradford WZ, Castro-Bernardini S, ASCEND Study Group et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370(22):2083–2092

    Article  PubMed  Google Scholar 

  9. Richeldi L, du Bois RM, Raghu G, INPULSIS Trial Investigators et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370(22):2071–2082

    Article  PubMed  Google Scholar 

  10. Barlo NP, van Moorsel CH, van den Bosch JM, Grutters JC (2010) Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 27(2):85–95

    CAS  PubMed  Google Scholar 

  11. Egan TM, Murray S, Bustami RT et al (2006) Development of the new lung allocation system in the United States. Am J Transplant 6(5 Pt 2):1212–1227

    Article  CAS  PubMed  Google Scholar 

  12. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE Jr, Collard HR (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156(10):684–691

    Article  PubMed  Google Scholar 

  13. du Bois RM, Albera C, Bradford WZ et al (2014) 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J 43(5):1421–1429

    Article  PubMed  Google Scholar 

  14. Raghu G, Collard HR, Anstrom KJ et al (2012) Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 185(10):1044–1048

    Article  PubMed  Google Scholar 

  15. Mackay LS, Anderson RL, Parry G et al (2007) Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation. Thorax 62(12):1069–1073

    Article  PubMed Central  PubMed  Google Scholar 

  16. Report 2014 Organizzazione Toscana Trapianti (OTT)

  17. Andreasson AS, Dark JH, Fisher AJ (2014) Ex vivo lung perfusion in clinical lung transplantation—state of the art. Eur J Cardiothorac Surg 46(5):779–788

    Article  PubMed  Google Scholar 

  18. Wigfield C (2014) Donation after cardiac death for lung transplantation: a review of current clinical practice. Curr Opin Organ Transplant 19(5):455–459

    PubMed  Google Scholar 

  19. Prasse A, Probst C, Bargagli E et al (2009) Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(8):717–723

    Article  CAS  PubMed  Google Scholar 

  20. Yokoyama A, Kondo K, Nakajima M et al (2006) Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 11(2):164–168

    Article  PubMed  Google Scholar 

  21. Richards TJ, Kaminski N, Baribaud F et al (2012) Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 185(1):67–76

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Bargagli E, Olivieri C, Cintorino M et al (2011) Calgranulin B (S100A9/MRP14): a key molecule in idiopathic pulmonary fibrosis? Inflammation 34(2):85–91

    Article  CAS  PubMed  Google Scholar 

  23. Bargagli E, Madioni C, Bianchi N et al (2014) Serum analysis of coagulation factors in IPF and NSIP. Inflammation 37(1):10–16

    Article  CAS  PubMed  Google Scholar 

  24. Korthagen NM, van Moorsel CH, Zanen P et al (2014) Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias. Lung 192(6):975–980

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Respiratory Diseases and Lung Transplantation Unit, Internal and Specialist Medicine Department, Azienda Ospedaliera Universitaria Senese (AOUS), Viale Bracci n° 16, 2nd Floor, 3rd Building, 53100, Siena, Italy

    David Bennett, Antonella Fossi, Elena Bargagli, Rosa Metella Refini, Maria Pieroni & Paola Rottoli

  2. Thoracic Surgery Unit, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera Universitaria Senese (AOUS), Siena, Italy

    Luca Luzzi, Claudia Ghiribelli, Piero Paladini & Luca Voltolini

Authors
  1. David Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonella Fossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Bargagli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosa Metella Refini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Pieroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luca Luzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Claudia Ghiribelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Piero Paladini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luca Voltolini
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Paola Rottoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Bennett.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bennett, D., Fossi, A., Bargagli, E. et al. Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience. Lung 193, 677–681 (2015). https://doi.org/10.1007/s00408-015-9767-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-015-9767-x

Keywords

Search

Navigation